Ligand validation:6N6X

ID1: Imipenem

ID1 is a Ligand Of Interest in 6N6X designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6N6X_ID1_A_301	45%	7%	0.182	0.912	2.21	2.52	4	3	0	0	100%	1
5WIB_ID1_B_301	71%	17%	0.131	0.951	2.08	1.53	3	3	1	0	100%	1
6N6U_ID1_A_301	56%	13%	0.116	0.886	2.2	1.74	3	2	0	0	100%	1
7PFN_ID1_BBB_301	84%	23%	0.109	0.972	0.84	2.31	1	2	1	0	100%	0.96
5EPH_ID1_C_302	83%	3%	0.105	0.962	2.41	3.7	4	5	0	0	100%	1
8AKK_ID1_A_301	76%	11%	0.108	0.945	1.77	2.38	2	3	0	0	100%	0.46
7Q14_ID1_AAA_301	62%	37%	0.128	0.921	1.25	1.24	2	-	1	0	100%	0.82

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.